| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paula Berman, Luis Alejandro de Haro, Adam Jozwiak, Sayantan Panda, Zoe Pinkas, Younghui Dong, Jelena Cveticanin, Ranjit Barbole, Rotem Livne, Tali Scherf, Eyal Shimoni, Smadar Levin-Zaidman, Nili Dezorella, Ekaterina Petrovich-Kopitman, Sagit Meir, Ilana Rogachev, Prashant D Sonawane, Asaph Aharon. Parallel evolution of cannabinoid biosynthesis. Nature plants. 2023-05-01. PMID:37127748. |
here we explored helichrysum umbraculigerum, an asteraceae species unrelated to cannabis sativa that produces cannabis-type cannabinoids (for example, 4.3% cannabigerolic acid). |
2023-05-01 |
2023-08-14 |
human |
| Paula Berman, Luis Alejandro de Haro, Adam Jozwiak, Sayantan Panda, Zoe Pinkas, Younghui Dong, Jelena Cveticanin, Ranjit Barbole, Rotem Livne, Tali Scherf, Eyal Shimoni, Smadar Levin-Zaidman, Nili Dezorella, Ekaterina Petrovich-Kopitman, Sagit Meir, Ilana Rogachev, Prashant D Sonawane, Asaph Aharon. Parallel evolution of cannabinoid biosynthesis. Nature plants. 2023-05-01. PMID:37127748. |
in contrast to cannabis, cannabinoids in h. umbraculigerum accumulate in leaves' glandular trichomes rather than in flowers. |
2023-05-01 |
2023-08-14 |
human |
| Paula Berman, Luis Alejandro de Haro, Adam Jozwiak, Sayantan Panda, Zoe Pinkas, Younghui Dong, Jelena Cveticanin, Ranjit Barbole, Rotem Livne, Tali Scherf, Eyal Shimoni, Smadar Levin-Zaidman, Nili Dezorella, Ekaterina Petrovich-Kopitman, Sagit Meir, Ilana Rogachev, Prashant D Sonawane, Asaph Aharon. Parallel evolution of cannabinoid biosynthesis. Nature plants. 2023-05-01. PMID:37127748. |
orthology analyses demonstrate that cannabinoid synthesis evolved in parallel in h. umbraculigerum and cannabis. |
2023-05-01 |
2023-08-14 |
human |
| Hang Li, Tian-Xiao Yang, Qing-Sheng Zhao, Shou-Bu Hou, Rong-Rong Tian, Bing Zha. Comparative study of encapsulated cannabidiol ternary solid dispersions prepared by different techniques: The application of a novel technique jet milling. Food research international (Ottawa, Ont.). vol 168. 2023-04-29. PMID:37120229. |
cannabidiol (cbd) is an important cannabinoid of hemp but poor aqueous solubility limited its applications. |
2023-04-29 |
2023-08-14 |
Not clear |
| Maitane Oscoz-Irurozqui, Carmen Almodóvar-Payá, Maria Guardiola-Ripoll, Amalia Guerrero-Pedraza, Noemí Hostalet, Raymond Salvador, Maria Isabel Carrión, Teresa Maristany, Edith Pomarol-Clotet, Mar Fatjó-Vila. Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis. International journal of molecular sciences. vol 24. issue 8. 2023-04-28. PMID:37108689. |
cannabis use and endocannabinoid receptor genes: a pilot study on their interaction on brain activity in first-episode psychosis. |
2023-04-28 |
2023-08-14 |
Not clear |
| Maitane Oscoz-Irurozqui, Carmen Almodóvar-Payá, Maria Guardiola-Ripoll, Amalia Guerrero-Pedraza, Noemí Hostalet, Raymond Salvador, Maria Isabel Carrión, Teresa Maristany, Edith Pomarol-Clotet, Mar Fatjó-Vila. Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis. International journal of molecular sciences. vol 24. issue 8. 2023-04-28. PMID:37108689. |
however, the effect of the interplay between cannabis and variability at the endocannabinoid receptor genes on the neurobiological underpinnings of psychosis remains inconclusive. |
2023-04-28 |
2023-08-14 |
Not clear |
| Maitane Oscoz-Irurozqui, Carmen Almodóvar-Payá, Maria Guardiola-Ripoll, Amalia Guerrero-Pedraza, Noemí Hostalet, Raymond Salvador, Maria Isabel Carrión, Teresa Maristany, Edith Pomarol-Clotet, Mar Fatjó-Vila. Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis. International journal of molecular sciences. vol 24. issue 8. 2023-04-28. PMID:37108689. |
through a case-only design, including patients with a first-episode of psychosis (n = 40) classified as cannabis users (50%) and non-users (50%), we aimed to evaluate the interaction between cannabis use and common genetic variants at the endocannabinoid receptor genes on brain activity. |
2023-04-28 |
2023-08-14 |
Not clear |
| Julio Salazar-Bermeo, Bryan Moreno-Chamba, María Concepción Martínez-Madrid, Manuel Valero, Joaquín Rodrigo-García, Farah Hosseinian, Francisco Martín-Bermudo, Manuel Aguado, Rosa de la Torre, Nuria Martí, Domingo Saur. Preventing Mislabeling: A Comparative Chromatographic Analysis for Classifying Medical and Industrial Cannabis. Molecules (Basel, Switzerland). vol 28. issue 8. 2023-04-28. PMID:37110787. |
gas chromatography (gc) techniques for analyzing and determining the cannabinoid profile in cannabis ( |
2023-04-28 |
2023-08-14 |
Not clear |
| Whitley J Stone, Danilo V Tolusso, Guiellermo Pancheco, Shea Brgoch, VAN T Nguye. A Pilot Study on Cannabidiol (CBD) and Eccentric Exercise: Impact on Inflammation, Performance, and Pain. International journal of exercise science. vol 16. issue 2. 2023-04-28. PMID:37114193. |
cannabidiol (cbd) is a non-psychoactive cannabinoid purported to reduce symptoms of discomfort. |
2023-04-28 |
2023-08-14 |
human |
| Eli J Borrego, Mariah Robertson, James Taylor, Zachary Schultzhaus, Elida M Espinoz. Oxylipin biosynthetic gene families of Cannabis sativa. PloS one. vol 18. issue 4. 2023-04-26. PMID:37099560. |
cannabis sativa is a global multi-billion-dollar cash crop with numerous industrial uses, including in medicine and recreation where its value is largely owed to the production of pharmacological and psychoactive metabolites known as cannabinoids. |
2023-04-26 |
2023-08-14 |
Not clear |
| Eli J Borrego, Mariah Robertson, James Taylor, Zachary Schultzhaus, Elida M Espinoz. Oxylipin biosynthetic gene families of Cannabis sativa. PloS one. vol 18. issue 4. 2023-04-26. PMID:37099560. |
this knowledge facilitates future targeted approaches towards cannabis crop improvement and for the manipulation of cannabinoid metabolism. |
2023-04-26 |
2023-08-14 |
Not clear |
| Michael F Santillo, Robert L Sprand. Predicting binding between 55 cannabinoids and 4799 biological targets by in silico methods. Journal of applied toxicology : JAT. 2023-04-26. PMID:37101313. |
cannabis contains over a hundred cannabinoids, many of which have unknown physiological effects. |
2023-04-26 |
2023-08-14 |
human |
| Richard B van Breemen, Daniel Simchu. Antiviral activities of hemp cannabinoids. Clinical science (London, England : 1979). vol 137. issue 8. 2023-04-21. PMID:37083031. |
after years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (cbd), Δ9-tetrahydrocannabinol (Δ9-thc), cannabidiolic acid (cbda), cannabigerolic acid (cbga), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (sars-cov-2), human immunodeficiency virus (hiv), and γ-herpes viruses. |
2023-04-21 |
2023-08-14 |
human |
| Noa Raz, Aharon M Eyal, Dana Berneman Zeitouni, Danielle Hen-Shoval, Elyad M Davidson, Aviel Danieli, Merav Tauber, Yair Ben-Chai. SELECTED CANNABIS TERPENES SYNERGIZE WITH THC TO PRODUCE INCREASED CB1 RECEPTOR ACTIVATION. Biochemical pharmacology. 2023-04-21. PMID:37084981. |
the cannabis plant exerts its pharmaceutical activity primarily by the binding of cannabinoids to two g protein-coupled cannabinoid receptors, cb1 and cb2. |
2023-04-21 |
2023-08-14 |
Not clear |
| Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freema. Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry. vol 13. issue 1. 2023-04-21. PMID:37085531. |
analyses were conducted both unadjusted and adjusted for cannabis use during the trial to account for effects of cannabis on the endocannabinoid system. |
2023-04-21 |
2023-08-14 |
human |
| Rafaela Silva Dos Santos, Flávio Protassio Veras, Gonçalves Pedro Netto, Carlos Alberto Sorgi, Lúcia Helena Faccioli, Luciano Rezende Vilela, Giovane Galdin. Cannabidiol reduces LPS-induced nociception via endocannabinoid system activation. Basic & clinical pharmacology & toxicology. 2023-04-20. PMID:37076976. |
cannabidiol reduces lps-induced nociception via endocannabinoid system activation. |
2023-04-20 |
2023-08-14 |
mouse |
| James R Lathrop, Sheldon N Rosen, Margaret M Heitkemper, Diana Taibi Buchana. Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome: The State of the Science. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates. 2023-04-19. PMID:37074964. |
a synopsis of the endocannabinoid system provides a basis for the hypothesis that a lack of cannabidiol in modern high-potency Δ9-tetrahydrocannabinol cannabis may be contributory to cannabis hyperemesis syndrome and possibly other cannabis use disorders. |
2023-04-19 |
2023-08-14 |
Not clear |
| Erica Wennberg, Sarah B Windle, Kristian B Filion, Brett D Thombs, Genevieve Gore, Andrea Benedetti, Roland Grad, Carolyn Ells, Mark J Eisenber. Roadside screening tests for cannabis use: A systematic review. Heliyon. vol 9. issue 4. 2023-04-17. PMID:37064483. |
we searched six databases (inception-march 2020) and grey literature sources for primary studies evaluating test characteristics of roadside screening tests for cannabis use compared to laboratory tests for cannabinoids in blood or oral fluid. |
2023-04-17 |
2023-08-14 |
Not clear |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
around the world, about 15 to 40% of individuals with inflammatory bowel disease (ibd) rely on cannabis and cannabinoids to reduce the need for other medications, as well as increase appetite and reduce pain. |
2023-04-17 |
2023-08-14 |
human |
| Basil N Nduma, Kelly A Mofor, Jason Tatang, Chukwuyem Ekhator, Solomon Ambe, Ekokobe Fonke. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. vol 15. issue 3. 2023-04-17. PMID:37065370. |
whereas more and more patients continue to report benefits accruing from cannabis and cannabinoid usage in ibd, agreement relative to the use of cannabis and its derivatives in ibd remains unclear. |
2023-04-17 |
2023-08-14 |
human |